Institutional Costs of Guideline-Concordant Care Non-Receipt among Women with Breast Cancer
Ann Surg Open
.
2024 Sep 24;5(4):e489.
doi: 10.1097/AS9.0000000000000489.
eCollection 2024 Dec.
Authors
Kriyana P Reddy
1
,
Oluwadamilola M Fayanju
1
2
3
4
,
Stephany Perez-Rojas
1
,
Terry Hyslop
5
,
S Yousuf Zafar
6
,
Justin Bekelman
2
3
4
7
,
E Shelley Hwang
8
9
Affiliations
1
From the Division of Breast Surgery, Department of Surgery, Perelman School of Medicine, The University of Pennsylvania, Philadelphia, PA.
2
Abramson Cancer Center, Penn Medicine, Philadelphia, PA.
3
Penn Center for Cancer Care Innovation, Abramson Cancer Center, Penn Medicine, Philadelphia, PA.
4
Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA.
5
Division of Biostatistics, Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, PA.
6
Department of Medicine, Duke University School of Medicine, Durham, NC.
7
Department of Radiation Oncology, Perelman School of Medicine, The University of Pennsylvania, Philadelphia, PA.
8
Duke Cancer Institute, Duke University, Durham, NC.
9
Department of Surgery, Duke University Medical Center, Durham, NC.
PMID:
39711651
PMCID:
PMC11661736
DOI:
10.1097/AS9.0000000000000489
No abstract available